PSC

Aug 12, 2019

Immunic, Inc. Announces First Patient Enrolled in Investigator-Sponsored Proof-of-Concept Clinical Trial of IMU-838 for the Treatment of Patients with Primary Sclerosing Cholangitis

Jun 11, 2019

BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan

Jan 17, 2019

PAE CEO Elected to PSC Executive Committee

Oct 03, 2018

HighTide Therapeutics Presented at the 2nd Annual Pediatric Autoimmune Liver Disease Symposium and Family Day

Sep 11, 2018

Global Primary Sclerosing Cholangitis Treatment Market 2018-2022: Key Vendors are Allergan, Glenmark, Impax Laboratories, Mylan & Teva Pharmaceuticals

Aug 02, 2018

PSC Biotech Corporation and PSC Software Announce Acquisition of Three of the Four Largest Pharmaceutical Companies as Customers of Adaptive Compliance Engine(TM) aka ACE

Apr 12, 2018

PSC Group Named As One Of The Best Places To Work By Crain's Chicago Business

Feb 20, 2018

DURECT Corporation to Host Key Opinion Leader Call on Treatment of Primary Sclerosing Cholangitis (PSC)

Aug 21, 2017

PSC and HydroChem Announce Agreement to Combine Companies

Aug 10, 2017

The AADE Selects PSC Group to Expand Technology Information Platform for Diabetes Educators